| Literature DB >> 32511702 |
Noor Hafizan Mat Salleh1, Mohd Faizal Abdul Rahman1, Samsiah Samsusah1, Jeremy Ryan De Silva2, David Chun-Ern Ng3, Azilawati Hanim Ghozali4, Jia Hui Tan2, Meng Yee Lai2, Amirah Amir2, Jonathan Wee Kent Liew2, Yee Ling Lau2.
Abstract
Five children in Pos Lenjang, Pahang, Malaysia were PCR-positive for vivax malaria and were admitted to the hospital from 5 to 26 July 2019. One of the patients experienced three episodes of recurrence of vivax malaria. Microsatellite analysis showed that reinfection is unlikely. Drug resistance analysis indicated that Riamet (artemether-lumefantrine) is effective. Cytochrome P450 2D6 (CYP2D6) testing showed that this patient has defective CYP2D6 function. Primaquine failure to clear the Plasmodium vivax hypnozoites may be the cause of recurring infections in this patient. This report highlights the need for the development of liver-stage curative antimalarials that do not require metabolism by the CYP2D6 enzyme.Entities:
Keywords: zzm321990 Plasmodium vivaxzzm321990 ; CYP2D6; drug resistance; mutation; recurrent
Mesh:
Substances:
Year: 2020 PMID: 32511702 DOI: 10.1093/trstmh/traa042
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN: 0035-9203 Impact factor: 2.184